| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Capricor Therapeutics, Inc. (CAPR) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. CAPR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 50.0K | $1.52M | - | |
| CEO | 50.0K | $1.52M | - | |
| VP | 22.5K | $682.4K | - | |
| Dir | 15.5K | $470.1K | - | |
| Dir | 15.5K | $470.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2015 | Manzo Louis | Director | Buy | 28,384 | $3.52 | $99,996.83 | New | |
| Jan 21, 2015 | Musket David B60 | Director | Buy | 70,962 | $3.52 | $249,999.13 | New | |
| Jan 21, 2015 | Grasmick Louis J | Director | Buy | 141,924 | $3.52 | $499,998.25 | +15.8% |